KLK3 and prostate carcinoma: Robert et al[11] considered that the increased PSA level, before radiotherapy, may be a prognostic indicator of radiotherapy and antiandrogen therapy for prostate cancer, and the antiandrogen treatment of patients receiving radiotherapy is related to the improvement of prognosis.